Safety and efficacy of azacitidine in myelodysplastic syndromes

PURPOSE: The clinical efficacy, different dosages, treatment schedules, and safety of azacitidine are reviewed. SUMMARY: Azacitidine is the first drug FDA-approved for the treatment of myelodysplastic syndromes that has demonstrated improvements in overall survival and delaying time to progression t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vigil, Carlos E, Martin-Santos, Taida, Garcia-Manero, Guillermo
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2010
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948932/
https://ncbi.nlm.nih.gov/pubmed/20957213
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki